When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
KLDO - Kaleido Biosciences launches study of KB109 in COVID-19 patients
Kaleido Biosciences Inc.
In partnership with Boston's Mass General Hospital, Kaleido Biosciences (NASDAQ:KLDO)initiates a non-IND clinical study evaluating Microbiome Metabolic Therapy (MMT) candidate KB109 on top of supportive self-care (SSC) in ~50 outpatients with mild-to-moderate COVID-19.
More news on: Kaleido Biosciences, Inc., Healthcare stocks news, Stocks on the move,